Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2016.00205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Triple-Negative Breast Cancer

2018English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Metabolic Consequences of HIF Silencing in a Triple Negative Human Breast Cancer Xenograft

Oncotarget
Oncology
2018English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Role of Immunotherapy in Triple-Negative Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2020English

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

Therapeutic Landscape in Mutational Triple Negative Breast Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

ADAR1 Editing Dependency in Triple-Negative Breast Cancer

2020English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy